An Earnings Overreaction in PetMed Express? (PETS)
May 7, 2012 by Jon C. Ogg
PetMed Express Inc. (NASDAQ: PETS) is far from your usual company. The company specializes in online drug orders for your pets and it is arguable enough that the company could eventually be considered a potential takeover candidate. The market cap after a large drop on Monday is now only $219 million.
The company beat earnings on the surface for the latest quarter as net income was $4 million, or $0.20 EPS, versus $4.1 million, or $0.19 EPS. The report shows that earnings per share was up while net income fell due to there being fewer shares on the market compared to a year ago. Revenue rose to $55.9 million from $50.9 million a year ago.
PetMed Express acquired about 162,000 new customers during the fourth quarter compared to 130,000 during the same period a year ago. That 25% increase allowed for the company to end its last fiscal year with a total yearly gain of approximately 722,000 customers compared to 645,000 for the year earlier. Online sales rose by 16% for the quarter and were up by 8% for the year ended March 31, 2012.
A higher operating cost bit into earnings in part due to advertising expenses. Shares are down by 19% at $11.12 against a 52-week range of $8.51 to $14.77. If the company can manage to hit its consensus earnings targets then this site trades at just over 14-times is new adjusted share price.
Any time you see a move like this it is hard to wonder if you are not seeing a large overreaction on that particular day.
JON C. OGG
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.